Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 May;29(5):873–876. doi: 10.1128/aac.29.5.873

Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.

D Charles, B Larsen
PMCID: PMC284170  PMID: 3729345

Abstract

Twelve parturient women volunteered to receive 1 g of cefotaxime on the second or third day postpartum by intravenous infusion over 3 min. Blood was taken from the antecubital vein of the contralateral arm at 0.25, 0.5, 0.75, 1, 2, 4, and 6 h. The concentration of cefotaxime in serum was assayed by agar diffusion, with Sarcina lutea ATCC 9341 as the indicator strain. The same 12 women received an identical dose of antibiotic 4 months after the first dose, and blood was taken at the same time intervals as in the first study to measure antibiotic levels. An additional 24 women participated in identical studies with either moxalactam or cefoperazone. Cefoperazone afforded the highest concentration in serum of the three drugs, followed by moxalactam. These differences in the concentration in serum were seen both early postpartum and 4 months later. However, the concentration in serum of all three drugs was diminished 2 and 3 days postpartum compared with 4 months postpartum. Most pharmacokinetic parameters were also significantly altered early in the puerperium relative to those obtained 4 months later. The altered pharmacokinetic behavior of antibiotics associated with pregnancy appears to persist into the early puerperium.

Full text

PDF
873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charles D., Larsen B. Pharmacokinetics of piperacillin in the postpartum patient. Gynecol Obstet Invest. 1985;20(4):194–198. doi: 10.1159/000298993. [DOI] [PubMed] [Google Scholar]
  2. Giamarellou H., Gazis J., Petrikkos G., Antsaklis A., Aravantinos D., Daikos G. K. A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy. Am J Obstet Gynecol. 1983 Dec 15;147(8):914–919. doi: 10.1016/0002-9378(83)90245-4. [DOI] [PubMed] [Google Scholar]
  3. Kafetzis D. A., Lazarides C. V., Siafas C. A., Georgakopoulos P. A., Papadatos C. J. Transfer of cefotaxime in human milk and from mother to foetus. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):135–141. doi: 10.1093/jac/6.suppl_a.135. [DOI] [PubMed] [Google Scholar]
  4. MacAulay M. A., Abou-Sabe M., Charles D. Placental transfer of ampicillin. Am J Obstet Gynecol. 1966 Dec 1;96(7):943–950. doi: 10.1016/0002-9378(66)90439-x. [DOI] [PubMed] [Google Scholar]
  5. Philipson A. Pharmacokinetics of ampicillin during pregnancy. J Infect Dis. 1977 Sep;136(3):370–376. doi: 10.1093/infdis/136.3.370. [DOI] [PubMed] [Google Scholar]
  6. Wise R., Wills P. J., Andrews J. M., Bedford K. A. Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob Agents Chemother. 1980 Jan;17(1):84–86. doi: 10.1128/aac.17.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES